Nadav Sarid

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Eligibility Matched Benchmarking of Second-Line Anti-CD19 Chimeric Antigen Receptor-T and Glofit-GemOx (STARGLO) Outcomes in Large B-Cell Lymphoma.

Eligibility Matched Benchmarking of Second-Line Anti-CD19 Chimeric Antigen Receptor-T and Glofit-GemOx (STARGLO) Outcomes in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: April 04, 2026

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Journal: British journal of haematology

Published: March 31, 2026

Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter's transformation: results from the phase II GIVeRS trial.

Fixed-duration obinutuzumab-ibrutinib-venetoclax for Richter's transformation: results from the phase II GIVeRS trial.

Journal: Haematologica

Published: February 19, 2026

Unveiling the invisible: the role of multimodality imaging in diagnosing primary cardiac lymphoma.

Unveiling the invisible: the role of multimodality imaging in diagnosing primary cardiac lymphoma.

Journal: The international journal of cardiovascular imaging

Published: February 12, 2026

ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study.

ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study.

Journal: Haematologica

Published: August 19, 2025

Myxedema Coma-associated Pancytopenia: A Case Report.

Myxedema Coma-associated Pancytopenia: A Case Report.

Journal: Rambam Maimonides medical journal

Published: November 06, 2024

Knowledge and Practices Regarding Prevention of Central Venous Catheter Removal-Associated Air Embolism: A Survey of Nonintensive Care Unit Medical and Nursing Staff.

Knowledge and Practices Regarding Prevention of Central Venous Catheter Removal-Associated Air Embolism: A Survey of Nonintensive Care Unit Medical and Nursing Staff.

Journal: Journal of patient safety

Published: October 25, 2024

Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional Study.

Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional Study.

Journal: Transplantation and cellular therapy

Published: July 31, 2024

A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.

A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.

Journal: Cancer

Published: September 27, 2022

Lymphoproliferative disease detected by breast cancer screening.

Lymphoproliferative disease detected by breast cancer screening.

Journal: Journal of medical screening

Published: July 12, 2022

Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population.

Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population.

Journal: Journal of clinical immunology

Published: May 13, 2022

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.

Journal: Annals of hematology

Published: October 25, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026